James "Rev Shark" DePorre

|RSS

James "Rev Shark" DePorre is the author of Invest Like a Shark: How a Deaf Guy With No Job and Limited Capital Made a Fortune Investing in the Stock Market. He is founder and CEO of Shark Asset Management, an investment management firm, and he also operates sharkinvesting.com, an interactive online community that serves and educates active investors.Expand

DePorre holds business and law degrees from the University of Michigan, is a member of the Michigan Bar Association and a former attorney and CPA. He lives in Anna Maria Island, Fla., and Conover, N.C., with his wife and three children. Under no circumstances does the information in this column represent a recommendation to buy or sell stocks.Collapse

RMPIA
By

James "Rev Shark" DePorre

 | Jul 21, 2017 | 4:56 PM EDT
After ripping higher earlier in the week, stocks went into consolidation mode Friday.
RMPIA
By

James "Rev Shark" DePorre

 | Jul 21, 2017 | 1:52 PM EDT
Adesto, Axcelis and InnerWorkings all have promising charts.
RMPIA
By

James "Rev Shark" DePorre

 | Jul 20, 2017 | 5:24 PM EDT
Catching a decent wave more about luck than skill.
By

James "Rev Shark" DePorre

 | Jul 20, 2017 | 10:19 AM EDT
Small investors are not fund managers, and there's no reason why they should invest as though they are.
By

James "Rev Shark" DePorre

 | Jul 19, 2017 | 4:56 PM EDT
Firing on all cylinders amid more record highs.
By

James "Rev Shark" DePorre

 | Jul 19, 2017 | 10:00 AM EDT
Despite talk of a downturn, I continue to stick to my routine and look for actionable ideas; and here are a few more for your consideration.
RMPIA
By

James "Rev Shark" DePorre

 | Jul 18, 2017 | 4:48 PM EDT
Netflix is the star as S&P, Nasdaq set records.
RMPIA
By

James "Rev Shark" DePorre

 | Jul 18, 2017 | 9:00 AM EDT
The bulls are still in favor, but we are entering the toughest 6-week period of the year for markets.
By

James "Rev Shark" DePorre

 | Jul 17, 2017 | 4:38 PM EDT
Monday's index action was quiet, but traders still found issues to play.
RMPIA
By

James "Rev Shark" DePorre

 | Jul 17, 2017 | 12:45 PM EDT
Biotech stocks provide pockets of momentum.

BEST IDEAS

News Breaks

Powered by
Except as otherwise indicated, quotes are delayed. Quotes delayed at least 20 minutes for all exchanges. Market Data provided by Interactive Data. Company fundamental data provided by Morningstar. Earnings and ratings provided by Zacks. Mutual fund data provided by Valueline. ETF data provided by Lipper. Powered and implemented by Interactive Data Managed Solutions.

TheStreet Ratings updates stock ratings daily. However, if no rating change occurs, the data on this page does not update. The data does update after 90 days if no rating change occurs within that time period.

IDC calculates the Market Cap for the basic symbol to include common shares only. Year-to-date mutual fund returns are calculated on a monthly basis by Value Line and posted mid-month.